Eyenovia, Inc.
General ticker "EYEN" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $11.4M (TTM average)
Eyenovia, Inc. follows the US Stock Market performance with the rate: 33.1%.
Estimated limits based on current volatility of 9.3%: low 4.71$, high 5.68$
Factors to consider:
- Total employees count: 14 (-75.4%) as of 2024
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.50$, 16.02$]
- 2025-12-31 to 2026-12-31 estimated range: [0.89$, 5.67$]
Short-term EYEN quotes
Long-term EYEN plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.06MM |
| Operating Expenses | $48.80MM |
| Operating Income | $-48.74MM |
| Non-Operating Income | $-1.08MM |
| Interest Expense | $2.48MM |
| R&D Expense | $14.46MM |
| Income(Loss) | $-49.82MM |
| Profit(Loss)* | $-49.82MM |
| Stockholders Equity | $-13.10MM |
| Assets | $3.67MM |
| Operating Cash Flow | $-30.12MM |
| Capital expenditure | $0.16MM |
| Investing Cash Flow | $-0.16MM |
| Financing Cash Flow | $17.55MM |
| Earnings Per Share** | $-59.81 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.